Influenza Diagnostics Market Worth $1.1 Billion by 2026 – Global Trends, Share Analysis, Leading Players, Business Opportunities
In May 2021 Becton, Dickinson and Company (US) received FDA approval for the BD Veritor Plus System, which is used to detect SARS-CoV-2, influenza A, and influenza B.
View full press release